NFKB1 and COVID-19: In contrast to other viral diseases such as COVID-19, it has been suggested that OEA, which is also upregulated only in TBE patients, is responsible for the downregulation of NFκB-related gene expression [52] and also modulates the effects partially mediated by PPARα [53].